OpenAI Blog
Paradigm has built a system using OpenAI's API to match patients with eligible clinical trials. The platform processes patient eligibility criteria against trial requirements to identify suitable matches. This reduces the administrative burden on patients and trial coordinators in finding appropriate studies.
Paradigm uses OpenAI’s API to improve patient access to clinical trials.
Collaborating on a nationwide randomized study of AI in real-world virtual care
Google Research · 5 months ago
AdventHealth advances whole-person care with OpenAI
OpenAI Blog · 1 month ago
Enabling a new model for healthcare with AI co-clinician
Google DeepMind · 2 months ago
The daily briefing
TLDRocket reads 60+ sources, removes duplicate coverage, and summarises the day in two minutes. Free, no spam, unsubscribe anytime.
TLDRocket
21 July 2026
The open-weight AI model market hit an inflection point today as Alibaba and Kimi released trillion-parameter competitors that challenge the closed-model orthodoxy—just as Washington moved to restrict them. Alibaba's Qwen 3.8 Max (2.4 trillion parameters) and Kimi K3 (2.8T) are going open-weight, with K3 ranking first on Frontend Web App Arena and fourth on agentic benchmarks, signaling that scale and transparency can coexist. The timing matters: while U.S. policymakers weigh layered restrictions on Chinese open models, technical experts are pushing back hard, arguing that closed gardens actually hurt security and competition more than they help. The real fragmentation risk isn't technical—it's regulatory.
Read the full briefing →